Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First Line Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06521866
What this trial is testing

Phase II Study of Serplulimab Combined with First-Line Targeted Therapy, Chemotherapy, and Radiation in Advanced Colorectal Cancer

Who this might be right for
Advanced Colorectal CarcinomaImmunotherapy
Fudan University 208
Large-scale testing (Phase 3)Ended earlyNCT01379976
What this trial is testing

Acetyl-L-carnitine in Combination With a Cisplatin-containing Chemotherapy as First Line Treatment of Advanced or Metastatic Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Mario Negri Institute for Pharmacological Research 107
Early research (Phase 1)Ended earlyNCT02018523
What this trial is testing

Lenalidomide Maintenance Therapy in Stage IIIB/IV Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Jun Zhang 7
Testing effectiveness (Phase 2)Study completedNCT02053376
What this trial is testing

Trial of Regorafenib as A Single Agent in Advanced and Metastatic Biliary Tract Carcinoma/Cholangiocarcinoma Patients Who Have Failed First-line Chemotherapy

Who this might be right for
Metastatic Biliary Tract Carcinoma
Nathan Bahary, MD 43
Testing effectiveness (Phase 2)Ended earlyNCT00431613
What this trial is testing

Study of Docetaxel/Gemcitabine Followed by Chemo-radiotherapy (Chemo-RT), With or Without Consolidation Chemotherapy, in IIIA/IIIB Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Hellenic Oncology Research Group 38
Testing effectiveness (Phase 2)Ended earlyNCT04856176
What this trial is testing

Sargramostim Plus Pembrolizumab with or Without Pemetrexed in Patients with Advance Non-small Cell Lung Cancer After Completion of Chemoimmunotherapy

Who this might be right for
Advanced Lung Non-Small Cell CarcinomaNon-Small Cell Carcinoma of Lung, TNM Stage 4
Tufts Medical Center 5
Testing effectiveness (Phase 2)Study completedNCT02705820
What this trial is testing

Switch Maintenance Pembrolizumab in Patients With NSCLC After First Line Platinum Doublet Chemotherapy

Who this might be right for
Metastatic Non Small Cell Lung Cancer
Bank of Cyprus Oncology Centre 48
Testing effectiveness (Phase 2)UnknownNCT02623010
What this trial is testing

Bruton's Tyrosine Kinase Inhibitor Ibrutinib as Maintenance Treatment in Elderly Patients With Primary CNS Lymphoma

Who this might be right for
Central Nervous System Lymphoma
Rabin Medical Center 30
Not applicableStudy completedNCT06030089
What this trial is testing

Plasma Dosage of Venetoclax in the Fup of AML Patients Treated With Aza + Ven

Who this might be right for
Acute Myeloid Leukemia
Centre Hospitalier Universitaire de Nice 20
Large-scale testing (Phase 3)Study completedNCT00457691
What this trial is testing

Study Of FOLFIRI Chemotherapy With Or Without Sunitinib In Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Pfizer 768
Testing effectiveness (Phase 2)UnknownNCT01921790
What this trial is testing

Avastin+ GemAOD As First-Line Treatment in NK/T Cell Lymphoma

Who this might be right for
Extranodal NK/T-cell Lymphoma, Nasal Type
Sun Yat-sen University 30
Testing effectiveness (Phase 2)Study completedNCT04623775
What this trial is testing

Relatlimab Plus Nivolumab in Combination With Chemotherapy vs. Nivolumab in Combination With Chemotherapy as First Line Treatment for Participants With Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung CancerRecurrent Non-small Cell Lung CancerMetastatic Non-small Cell Lung Cancer
Bristol-Myers Squibb 468
Large-scale testing (Phase 3)Active Not RecruitingNCT03315364
What this trial is testing

Oral Paclitaxel Trial In Recurrent and Metastatic Breast Cancer As 1st Line Therapy

Who this might be right for
Recurrent or Metastatic Breast Cancer
Daehwa Pharmaceutical Co., Ltd. 549
Testing effectiveness (Phase 2)UnknownNCT04620837
What this trial is testing

Tislelizumab in Combination With Anlotinib With ES-SCLC as Maintenance Therapy After First Line Chemotherapy

Who this might be right for
Small Cell Lung Carcinoma
Chinese Academy of Medical Sciences 25
Not applicableStudy completedNCT01266564
What this trial is testing

An Observational Study of Avastin (Bevacizumab) in Patients With Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 205
Large-scale testing (Phase 3)Study completedNCT04205812
What this trial is testing

Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Squamous Non-Small Cell Lung CancerMetastatic Nonsquamous Non-Small Cell Lung Cancer
Incyte Corporation 583
Large-scale testing (Phase 3)UnknownNCT01586611
What this trial is testing

See if hENT1 Testing on Tumour Tissue Can Predict Response to Treatment With Gemcitabine Chemotherapy and if a Different Chemotherapy Called FOLFOX is Better Than Gemcitabine in Metastatic Pancreas Cancer

Who this might be right for
Metastatic Pancreas Cancer
AHS Cancer Control Alberta 175
Testing effectiveness (Phase 2)UnknownNCT04094909
What this trial is testing

Rh-endostatin Combined With Chemotherapy and Pembrolizumab for Advanced NSCLC

Who this might be right for
Staging IV NSCLC
Guangzhou Institute of Respiratory Disease 186
Large-scale testing (Phase 3)UnknownNCT03855384
What this trial is testing

Study of TQB2450 in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck（R/M SCCHN）

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 334
Testing effectiveness (Phase 2)UnknownNCT05207904
What this trial is testing

Tislelizumab Plus Chemotherapy as First-Line Treatment for Advanced Squamous NSCLC With Brain Metastases

Who this might be right for
Non-Small Cell Squamous Lung CancerBrain Metastases
Sun Yat-sen University 41
Next Page